Brii Biosciences racks up $260 mln
Brii Biosciences, which is focused on improving public health in China, has raised $260 million in funding. The investors include ARCH Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital and Blue Pool Capital.
24 May 2018•1 min read
